OHR Synbiosis

Sustainable Bio-Based Manufacturing Solutions

Industrial Technologies
Private
Follow

Company Overview

Snapshot

Founded in January 2024 by Dan Davidi, OHR Synbiosis operates with 11–50 employees. The company is currently in a Pre-Funding stage, focusing on developing its sustainable chemical manufacturing platform.

Business overview

OHR Synbiosis is a synthetic biology company that develops a novel platform for sustainable chemical manufacturing. The company leverages engineered enzymes to transform CO₂-derived feedstocks into precise carbon chains, aiming to eliminate the need for traditional petroleum-based refining processes. This technology enables the production of bio-based materials, such as sulfur-free fuels, supporting decarbonization and circular economy solutions. OHR Synbiosis offers a scalable and cost-effective alternative to conventional petrochemical manufacturing, with applications across various industries, operating within the Industrial Technologies sector, specifically in Material Innovations & Applications and Sustainable Materials & Circularity.

Log in to access full profile

Company Intelligence Q&A

What is OHR Synbiosis's primary focus?
OHR Synbiosis focuses on developing a novel platform for sustainable chemical manufacturing using synthetic biology.
When was OHR Synbiosis founded?
OHR Synbiosis was founded in January 2024.
Who is the founder of OHR Synbiosis?
Dan Davidi is the founder and CEO of OHR Synbiosis.
What technology does OHR Synbiosis utilize?
OHR Synbiosis leverages engineered enzymes to transform CO₂-derived feedstocks into precise carbon chains, offering an alternative to petroleum-based refining.
What kind of materials does OHR Synbiosis aim to produce?
OHR Synbiosis aims to produce bio-based materials, including sulfur-free fuels, to support decarbonization and circular economy solutions.
Log in to access full profile